Skip to main content

Market Overview

New, Heart-Attack Risk Forecast Gains Increasing Importance During Polar Vortex


Toronto, Ontario and New York, New York, Feb. 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Big Data Media Inc. (BDM), a Toronto-based media company and wholly owned subsidiary of Luminar Media Group, Inc., ((Luminar, OTC:LRGR), and Ascel Bio, a New York–based public health forecasting and consulting company, have made their Heart Attack Risk Forecast (Beta) Map available for free to the public during the period of freezing temperatures associated with the record-setting cold air mass covering most of the eastern United States. The maps, which are updated hourly, are found at

The Heart Attack Risk map was launched in Beta form in late 2018 by DiseaseCast.  It is the first display in the U.S. of heart attack risks caused by weather conditions. It draws from official weather data and peer-reviewed academic studies proving links between weather conditions and heart attacks.

DiseaseCast is a consumer-focused disease risk forecasting site and mobile application. The site is powered by Big Data Media, a subsidiary of Luminar Media Group. DiseaseCast presents America's only zip code specific forecast for chronic and infectious disease risks, such as influenza. Output from multiple models for risks are displayed. These include, human and avian influenza risk, foodborne and waterborne diseases, mosquito diseases, as well as heart attack risks.  The site has unique visualizations that resemble weather forecast maps.  The risk maps are derived from reliable environmental and public health data, and Ascel Bio uses operationally proven and peer reviewed assessment approaches.  Models and approaches were first used by Ascel Bio in clinical settings since 2011.

"Luminar is pleased to present this critical, life-saving tool to the public," said Chris Cook, Chief Executive Officer. "The Heart Attack Risk map is an important addition to the offering, because it is a move beyond infectious disease prevention and into forecasting of chronic disease risks."

"There is solid scientific proof that animals of all kinds are stressed by extreme weather, and that these stresses have an impact on health," says chief bio-meteorologist Mike Smith.  "Ascel Bio has been forecasting influenza risks associated with extreme weather changes on humans and birds for years, and this Heart Attack Risk map is an extension of our work in this area."

Mr. Mike Smith 
Chief Bio-Meteorologist
Ascel Bio Inc.
(316) 636-7373

About Diseasecast

Diseasecast is a partnership between Ascel Bio Inc. (Ascel) and Big Data Media (BDM) , a subsidiary of Luminar Media Group ((Luminar, OTC:LRGR) to develop, a consumer-focused disease risk forecasting site and mobile application. The site is powered by BDM using Ascel's proprietary APIs to generate forecasts from various health and meteorological data sources. is America's only zip code specific forecast for chronic and infectious disease risks, such as influenza.

About Luminar: 

The Luminar Media Group has extensive knowledge and experience in the media, marketing and entertainment industries.  Our company was started by entrepreneurs that have a vision to identify new tools to communicate with the audience.  Our presence is a natural response to a new way of working in a changing landscape. At Luminar, we embrace the challenge of the constantly evolving business landscape and our determined culture will develop solutions.

About Ascel Bio:

Ascel Bio produces proprietary news and analysis for customers who share an interest in disease outbreaks and recognize the importance of filling gaps in local public health information.  Ascel's value-added content has been distributed under license to physicians, corporate chief medical officers and business continuity analysts, government crisis managers, quarantine officers, and health officials, and to community groups directly.  Our team delivers insight, promotes awareness, and supports education.

Forward-Looking Statements

This news release contains forward-looking statements about our business, or financial condition and prospects, that reflect our assumptions and beliefs based on information currently available. The Company can give no assurance that the expectations indicated by such forward-looking statements will be realized. There may be other risks and circumstances that we are unable to predict. When used in this news release, words such as "believes," "expects," "intends," "plans," "anticipates," "estimates" and similar expressions are intended to identify forward-looking statements, although there may be certain forward-looking statements not accompanied by such expressions. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including risks discussed in the company's periodic reports that are filed with the Securities and Exchange Commission and available on its website ( All forward-looking statements attributable to the Company or to persons acting on its behalf are expressly qualified in their entirety by these factors other than as required under the securities laws. The Company does not assume a duty to update these forward-looking statements.

Investors should refer to the risk factors disclosure outlined in our periodic reports filed from time-to-time with the Securities and Exchange Commission.

Luminar Media Group Investor Relations


View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at